Review article: Bone density in patients with chronic kidney disease stages 4-5

Nephrology

Volumn 14, Issue 4, 2009, Pages 395-403

  Ott, Susan M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Absorptiometry; Bone; Bone density; Fractures; Osteoporosis; Photon

Indexed keywords

PARATHYROID HORMONE;

ARTICLE; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CHRONIC KIDNEY DISEASE; CORTICAL BONE; DIALYSIS; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; HEMODIALYSIS; HIP FRACTURE; HISTOPATHOLOGY; HUMAN; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; RHEUMATOID ARTHRITIS; RISK FACTOR;

BONE DENSITY; FRACTURES, BONE; HUMANS; INCIDENCE; OSTEOPOROSIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RENAL OSTEODYSTROPHY; SEVERITY OF ILLNESS INDEX;

EID: 67650739481     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01159.x     Document Type: Article

References (104)

1. Pendras JP, Erickson RV. Hemodialysis: A successful therapy for chronic uremia. Ann. Intern. Med. 1966 64 : 293 311.
2. Rubini ME, Cobun JW, Massry SG, Shinaberger JH. Renal osteodystrophy; some therapeutic consideration relative to long-term dialysis and transplantation. Arch. Intern. Med. 1969 124 : 663 9.
3. Parfitt AM, Massry SG, Winfield AC. Osteopenia and fractures occurring during maintenance hemodialysis. A new form of renal osteodystrophy. Clin. Orthop. Relat. Res. 1972 87 : 287 302.
4. Yamaguchi T, Kanno E, Tsubota J, Shiomi T, Nakai M, Hattori S. Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures. Bone 1996 19 : 549 55.
5. Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T. Risk factors for vertebral fractures in renal osteodystrophy. Am. J. Kidney Dis. 1999 33 : 287 93.
6. Gerakis A, Hadjidakis D, Kokkinakis E, Apostolou T, Raptis S, Billis A. Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis. J. Nephrol. 2000 13 : 437 43.
7. Alem AM, Sherrard DJ, Gillen DL et al. Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int. 2000 58 : 396 9.
8. Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am. J. Kidney Dis. 2000 36 : 1115 21.
9. Stehman-Breen CO, Sherrard DJ, Alem AM et al. Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int. 2000 58 : 2200 5.
10. Ball AM, Gillen DL, Sherrard D et al. Risk of hip fracture among dialysis and renal transplant recipients. Jama. 2002 288 : 3014 18.
11. Jamal SA, Chase C, Goh YI, Richardson R, Hawker GA. Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures. Am. J. Kidney Dis. 2002 39 : 843 9.
12. Kaji H, Suzuki M, Yano S et al. Risk factors for hip fracture in hemodialysis patients. Am. J. Nephrol. 2002 22 : 325 31.
13. Urena P, Bernard-Poenaru O, Ostertag A et al. Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol. Dial. Transpl. 2003 18 : 2325 31.
14. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J. Am. Soc. Nephrol. 2004 15 : 2208 18.
15. Inaba M, Okuno S, Kumeda Y, Yamakawa T, Ishimura E, Nishizawa Y. Increased incidence of vertebral fracture in older female hemodialyzed patients with type 2 diabetes mellitus. Calcif. Tissue Int. 2005 76 : 256 60.
16. Ersoy FF, Passadakis SP, Tam P et al. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients. J. Bone Miner. Metab. 2006 24 : 79 86. (Pubitemid 41821508)
17. Jadoul M, Albert JM, Akiba T et al. Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2006 70 : 1358 66.
18. Jamal SA, Gilbert J, Gordon C, Cortical BAUER DC. pQCT measures are associated with fractures in dialysis patients. J. Bone Miner. Res. 2006 21 : 543 8.
19. Mitterbauer C, Kramar R, Oberbauer R. Age and sex are sufficient for predicting fractures occurring within 1 year of hemodialysis treatment. Bone 2007 40 : 516 21.
20. Ott SM, O'Hanlan M, Lipkin EW, Newell-Morris L. Evaluation of vertebral volumetric vs. areal bone mineral density during growth. Bone 1997 20 : 553 6.
21. Nottestad SY, Baumel JJ, Kimmel DB, Recker RR, Heaney RP. The proportion of trabecular bone in human vertebrae. J. Bone Miner. Res. 1987 2 : 221 9.
22. Leonard MB. A structural approach to the assessment of fracture risk in children and adolescents with chronic kidney disease. Pediatr. Nephrol. 2007 22 : 1815 24.
23. Zhang XH, Liu XS, Vasilic B et al. In vivo microMRI-based finite element and morphological analyses of tibial trabecular bone in eugonadal and hypogonadal men before and after testosterone treatment. J. Bone Miner. Res. 2008 23 : 1426 34.
24. Johnell O, Kanis JA, Oden A et al. Predictive value of BMD for hip and other fractures. J. Bone Miner. Res. 2005 20 : 1185 94.
25. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos. Int. 2008 19 : 385 97.
26. Kanis JA, Oden A, Johnell O et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos. Int. 2007.
27. Klawansky S, Komaroff E, Cavanaugh PF et al. Relationship between age, renal function and bone mineral density in the US population. Osteoporos. Int. 2003 14 : 570 76.
28. Hsu CY, Cummings SR, McCulloch CE, Chertow GM. Bone mineral density is not diminished by mild to moderate chronic renal insufficiency. Kidney Int. 2002 61 : 1814 20.
29. Haas M, Leko-Mohr Z, Roschger P et al. Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients. Am. J. Kidney Dis. 2002 39 : 580 86.
30. Elder GJ, Mackun K. 25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease. J. Bone Miner. Res. 2006 21 : 1778 84.
31. Cohn SH, Cinque TJ, Dombrowski CS, Letteri JM. Determination of body composition by neutron activation analysis in patient with renal failure. J. Lab. Clin. Med. 1972 79 : 978 94.
32. Griffiths HJ, Zimmerman RE, Bailey G, Snider R. The use of photon absorptiometry in the diagnosis of renal osteodystrophy. Diagn.Radiol. 1973 109 : 277 81.
33. Cohn SH, Ellis KJ, Caselnova RC, Asad SN, Letteri JM. Correlation of radial bone mineral content with total body calcium in chronic renal failure. J. Lab. Clin. Med. 1975 86 : 910 19.
34. Parfitt A, Oliver I, Walczak N, Levin N, Santiago G, Cruz C. The effect of chronic renal failure and maintenance hemodialysis on bone mineral content of the radius. Am. J. Roentg. 1976 126 : 1292 93.
35. Rickers H, Nielsen AH, Smith Pederson R, Rodbro P. Bone mineral loss during maintenance hemodialysis. Acta Med. Scand. 1978 204 : 263 7.
36. Aird EGA, Pierides AM. Photon absorptiometry in hemodialysis and transplant patients in Newcastle upon Tyne, England. In : Mazess R, ed. Proceedings of the Fourth International Conference on Bone Measurement. Bethesda : US Department of Health and Human Services, 1980 NIH Publication No. 80-1938 : 217 30.
37. Bailey RR, Stokes A. Bone mineral content of patients on hemodialysis and following renal transplantation. In : Mazess R, ed. Proceedings of the Fourth International Conference on Bone Measurement. Bethesda : US Department of Health and Human Services, 1980 NIH Publication No. 80-1938 : 211 6.
38. Heaf J, Nielsen LP, Mogensen NB. Use of bone mineral content determination in the evaluation of osteodystrophy among hemodialysis patients. Nephron 1983 35 : 103 07.
39. Rickers H, Christensen M, Rodbro P. Bone mineral content in patients on prolonged maintenance hemodialysis: A three year follow-up study. Clin. Nephrol. 1983 20 : 302 07.
40. Eastell R, Kennedy NSJ, Smith MA, Tothill P, Anderton JL. Changes in total body calcium after renal transplantation: Effect of low-dose steroid regime. Nephron 1985 40 : 139 42.
41. Lindergard B, Johnell O, Nilsson BE, Wiklung PE. Studies of bone morphology, bone densitometry, and laboratory data in patients on maintenance hemodialysis treatment. Nephron 1985 39 : 122 9.
42. Marumo F, Sakurai K, Sato N, Shimada H, Iwanami S. Deranged mineral content in the bone of patients with chronic renal failure, estimated by computed tomography. Int. J. Artif. Organs. 1985 8 : 95 100. (Pubitemid 15111849)
43. Schuster VL, Chesnut CH, Baylink DJ, Sherrard DJ. Calcium balance in uremia: Longitudinal study of long-term survivors. Nephron 1985 41 : 132 40.
44. Eeckhout E, Verbeelen D, Sennesael J, Kaufman L, Jonckheer MH. Monitoring of bone mineral content in patients on regular hemodialysis. Nephron 1989 52 : 158 61.
45. Julian B, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJQ. Rapid loss of vertebral mineral density after renal transplantation. N. Engl. J. Med. 1991 325 : 544 50.
46. Asaka M, Iida H, Entani C et al. Total and regional bone mineral density by dual photon absorptiometry in patients on maintenance hemodialysis. Clin. Nephrol. 1992 38 : 149 53.
47. Chan T, Pun KK, Cheng IK. Total and regional bone densities in dialysis patients. Nephrol. Dial. Transpl. 1992 7 : 835 9.
48. Gabay C, Ruedin P, Slosman D, Bonjour JP, Leski M, Rizzoli R. Bone mineral density in patients with end-stage renal failure. Am. J. Nephrol. 1993 13 : 115 23.
49. Hutchison AJ, Whitehouse RW, Boulton HF, Adams JE, Mawer EBF, Gokal R. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int. 1993 44 : 1071 7.
50. Kaye M, Rosenthall L, Hill RO, Tabah RJ. Long-term outcome following total parathyroidectomy in patients with end-stage renal disease. Clin. Nephrol. 1993 39 : 192 7.
51. Moe SM, Yu BO, Sprague SM. Maintenance of bone mass in patients receiving dialytic therapy. Am. J. Kidney Dis. 1993 22 : 300 7.
52. Lechleitner P, Krimbacker E, Genser N et al. Bone mineral densitometry in dialyzed patients: Quantitative computed tomography versus dual photon absorptiometry. Bone 1994 15 : 387 91.
53. Ruedin P, Rizzoli R, Slosman D, Leski M, Bonjour JP. Effects of oral calcitriol on bone mineral density in patients with end-stage renal failure. Kidney Int. 1994 45 : 245 52.
54. Mottet JJ, Horber FF, Casez JP, Descoeudres C, Jaeger P. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis. J. Bone Miner. Res. 1996 11 : 96 104. (Pubitemid 26026749)
55. Stein MS, Packham DK, Ebeling PR, Wark JD, Becker GJ. Prevalence and risk factors for osteopenia in dialysis patients. Am. J. Kidney Dis. 1996 28 : 515 22.
56. Spindler A, Paz S, Berman A et al. Muscular strength and bone mineral density in haemodialysis patients. Nephrol. Dial. Transpl. 1997 12 : 128 32.
57. Russo CR, Taccetti G, Caneva P, Mannarino A, Maranghi P, Ricca M. Volumetric bone density and geometry assessed by peripheral quantitative computed tomography in uremic patients on maintenance hemodialysis. Osteoporos. Int. 1998 8 : 443 8.
58. Stehman-Breen CO, Sherrard D, Walker A, Sadler R, Alem A, Lindberg J. Racial differences in bone mineral density and bone loss among end-stage renal disease patients. Am. J. Kidney Dis. 1999 33 : 941 6.
59. Taal MW, Masud T, Green D, Cassidy MJ. Risk factors for reduced bone density in haemodialysis patients. Nephrol. Dial. Transpl. 1999 14 : 1922 8.
60. Arici M, Erturk H, Altun B et al. Bone mineral density in haemodialysis patients: A comparative study of dual-energy X-ray absorptiometry and quantitative ultrasound. Nephrol. Dial. Transpl. 2000 15 : 1847 51.
61. Fan SL, Almond MK, Ball E, Evans K, Cunningham J. Pamidronate therapy as prevention of bone loss following renal transplantation. Kidney Int. 2000 57 : 684 90.
62. Kokado Y, Takahara S, Ichimaru N et al. Factors influencing vertebral bone density after renal transplantation. Transpl. Int. 2000 13 (Suppl 1 S431 5.
63. Barnas U, Schmidt A, Seidl G, Kaider A, Pietschmann P, Mayer G. A comparison of quantitative computed tomography and dual X-ray absorptiometry for evaluation of bone mineral density in patients on chronic hemodialysis. Am. J. Kidney Dis. 2001 37 : 1247 52.
64. Baszko-Blaszyk D, Grzegorzewska AE, Horst-Sikorska W, Sowinski J. Bone mass in chronic renal insufficiency patients treated with continuous ambulatory peritoneal dialysis. Adv. Perit. Dial. 2001 17 : 109 13.
65. Casez JP, Lippuner K, Horber FF, Montandon A, Jaeger P. Changes in bone mineral density over 18 months following kidney transplantation: The respective roles of prednisone and parathyroid hormone. Nephrol. Dial. Transpl. 2002 17 : 1318 26.
66. Hampson G, Vaja S, Evans C et al. Comparison of the humoral markers of bone turnover and bone mineral density in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephron 2002 91 : 94 102. (Pubitemid 34522838)
67. Pecovnik Balon B, Hojs R, Zavratnik A, Kos M. Bone mineral density in patients beginning hemodialysis treatment. Am. J. Nephrol. 2002 22 : 14 17. (Pubitemid 34264181)
68. Ghazali A, Grados F, Oprisiu R et al. Bone mineral density directly correlates with elevated serum leptin in haemodialysis patients. Nephrol. Dial. Transpl. 2003 18 : 1882 90.
69. Kato A, Odamaki M, Yamamoto T et al. Influence of body composition on 5 year mortality in patients on regular haemodialysis. Nephrol. Dial. Transpl. 2003 18 : 333 40.
70. Mikuls TR, Julian BA, Bartolucci A, Saag KG. Bone mineral density changes within six months of renal transplantation. Transplantation. 2003 75 : 49 54. (Pubitemid 36139694)
71. Nakashima A, Yorioka N, Doi S et al. Radial bone mineral density in hemodialysis patients with adynamic bone disease. Int. J. Artif. Organs. 2003 26 : 200 4.
72. Zayour D, Daouk M, Medawar W, Salamoun M, El-Hajj Fuleihan G. Predictors of bone mineral density in patients on hemodialysis. Transpl. Proc. 2004 36 : 1297 301.
73. Crisafulli A, Romeo A, Floccari F et al. Osteoprotegerin and bone mineral density in hemodiafiltration patients. Ren. Fail. 2005 27 : 531 9.
74. Inaba M, Okuno S, Imanishi Y et al. Significance of Bio-intact PTH(1-84) assay in hemodialysis patients. Osteoporos. Int. 2005 16 : 517 25.
75. Wetmore JB, Benet LZ, Kleinstuck D, Frassetto L. Effects of short-term alendronate on bone mineral density in haemodialysis patients. Nephrology (Carlton) 2005 10 : 393 9.
76. Nakashima A, Yorioka N, Doi S, Takasugi N, Shigemoto K, Kohno N. Osteoprotegerin and bone mineral density in hemodialysis patients. Osteoporos. Int. 2006 17 : 841 6.
77. Dolgos S, Hartmann A, Bonsnes S et al. Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation. Clin. Transpl. 2008 22 : 462 8.
78. Mares J, Ohlidalova K, Opatrna S, Ferda J. Determinants of prevalent vertebral fractures and progressive bone loss in long-term hemodialysis patients. J. Bone Miner. Metab. 2009.
79. Fontaine MA, Albert A, Dubois B, Saint-Remy A, Rorive G. Fracture and bone mineral density in hemodialysis patients. Clin. Nephrol. 2000 54 : 218 26.
80. Negri AL, Barone R, Quiroga MA et al. Bone mineral density: Serum markers of bone turnover and their relationships in peritoneal dialysis. Perit. Dial. Int. 2004 24 : 163 8.
81. Jamal SA, Hayden JA, Beyene J. Low bone mineral density and fractures in long-term hemodialysis patients: A meta-analysis. Am. J. Kidney Dis. 2007 49 : 674 81.
82. Ott SM. When bone mass fails to predict bone failure. Calcif. Tissue Int. 1993 53 (Suppl 1 S7 13.
83. Dukas L, Schacht E, Stahelin HB. In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml/min is a risk factor for falls and fractures. Osteoporos. Int. 2005 16 : 1683 90.
84. Torres A, Lorenzo V, Gonzalez-Posada JM. Comparison of histomorphometry and computerized tomography of the spine in quantitating trabecular bone in renal osteodystrophy. Nephron 1986 44 : 282 87.
85. Van Eps CL, Jeffries JK, Anderson JA et al. Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis. Nephrology (Carlton) 2007 12 : 224 33.
86. DeVita MV, Rasenas LL, Bansal M et al. Assessment of renal osteodystrophy in hemodialysis patients. Medicine (Baltimore) 1992 71 : 284 90.
87. Schober HC, Han ZH, Foldes AJ et al. Mineralized bone loss at different sites in dialysis patients: Implications for prevention. J. Am. Soc. Nephrol. 1998 9 : 1225 33.
88. Hutchison AJ, Whitehouse RW, Boulton HF, Adams JE, Mawer EBF, Gokal R. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int. 1993 44 : 1071 7.
89. Boling EP, Primavera C, Friedman G, King M, Bosserman LSE, Goodman WG. Non-invasive measurements of bone mass in adult renal osteodystrophy. Bone 1993 14 : 409 13.
90. Fletcher S, Jones RG, Rayner HC et al. Assessment of renal osteodystrophy in dialysis patients: Use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology. Nephron 1997 75 : 412 19.
91. Taal MW, Roe S, Masud T, Green D, Porter C, Cassidy MJ. Total hip bone mass predicts survival in chronic hemodialysis patients. Kidney Int. 2003 63 : 1116 20.
92. Ueda M, Inaba M, Okuno S et al. Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients. Am. J. Kidney Dis. 2002 40 : 802 9.
93. Wittersheim E, Mesquita M, Demulder A et al. OPG, RANK-L, bone metabolism, and BMD in patients on peritoneal dialysis and hemodialysis. Clin. Biochem. 2006 39 : 617 22.
94. Sit D, Kadiroglu AK, Kayabasi H, Atay AE, Yilmaz Z, Yilmaz ME. Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients. Adv. Ther. 2007 24 : 987 95.
95. Doumouchtsis KK, Kostakis AI, Doumouchtsis SK et al. Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients. J. Bone Miner. Metab. 2008 26 : 66 72. (Pubitemid 350307998)
96. Baim S, Wilson CR, Lewiecki EM, Luckey MM, Downs RW, Jr., Lentle BC. Precision assessment and radiation safety for dual-energy X-ray absorptiometry: Position paper of the International Society for Clinical Densitometry. J. Clin. Densitom. 2005 8 : 371 8.
97. Leslie WD. Factors affecting short-term bone density precision assessment and the effect on patient monitoring. J. Bone Miner. Res. 2008 23 : 199 204. (Pubitemid 351160033)
98. Bonnick SL, Shulman L. Monitoring osteoporosis therapy: Bone mineral density, bone turnover markers, or both? Am. J. Med. 2006 119 : S25 31.
99. Riggs BL, Hodgson SF, O'Fallon WM et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N. Engl. J. Med. 1990 322 : 802 9.
100. Bauer DC, Black DM, Garnero P et al. Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: The fracture intervention trial. J. Bone Miner. Res. 2004 19 : 1250 58.
101. Boivin G, Meunier PJ. Effects of bisphosphonates on matrix mineralization. J. Musculoskelet Neuronal Interact. 2002 2 : 538 43.
102. Sarkar S, Reginster JY, Crans GG, Diez-Perez A, Pinette KV, Delmas PD. Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk. J. Bone Miner. Res. 2004 19 : 394 401. (Pubitemid 38787394)
103. Bauer DC, Garnero P, Hochberg MC et al. Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: The fracture intervention trial. J. Bone Miner. Res. 2006 21 : 292 9.
104. Bergner R, Henrich D, Hoffmann M, Schmidt-Gayk H, Lenz T, Upperkamp M. Treatment of reduced bone density with ibandronate in dialysis patients. J. Nephrol. 2008 21 : 510 16.